School of Medicine

Class Acts celebrates graduates who are working for health equity across the globe, in their neighborhoods and in examination rooms. Meet Gautam Adusumilli and Cory French, doctor of medicine candidates from the School of Medicine, and Keishi Foecke, who is set to earn an undergraduate degree from Arts & Sciences.

Jean Allman and Lilianna Solnica-Krezel will receive Washington University’s 2021 faculty achievement awards, Chancellor Andrew D. Martin announced. Also, Aaron DiAntonio and Jeffrey Milbrandt, at the School of Medicine, will be recognized for innovation and entrepreneurship.

A new study led by the School of Medicine has found a link between consuming sugary drinks and an increased risk of colorectal cancer among women under 50. The findings could help explain the rising rates of colorectal cancer among younger adults.

Michael Evan Hughes, a neuroscientist and chronobiologist highly respected for his research at the School of Medicine, died May 4 at his home in St. Louis after a six-year battle with brain cancer. He was 41. A public celebration of life will be held Saturday, May 8, in Olivette, Mo.

J. Gmerice Hammond, MD, a cardiologist and health policy research fellow in the Cardiovascular Division at Washington University School of Medicine, has received a Merck Fellowship Research Award from the Association of Black Cardiologists and the American College of Cardiology.

Elliot Elson, of Washington University School of Medicine, has been elected to the National Academy of Sciences. Election to the academy is considered one of the highest honors that can be awarded to a U.S. scientist or engineer.

David D. Limbrick, MD, PhD, the T. S. Park, MD, Professor of Pediatric Neurosurgery at the School of Medicine, has been appointed to the St. Louis Regional Health Commission as the representative from the School of Medicine.

New research in mice has shown that some investigational Alzheimer’s therapies are more effective when paired with a treatment geared toward improving drainage of fluid and debris from the brain, according to a study led by researchers at Washington University School of Medicine.

A first-of-its kind device that helps people disabled by stroke regain significant control over their arm and hand function by using their minds has received market authorization from the Food and Drug Administration. The system developed by Neurolutions Inc., a WashU startup, relied on innovative multidisciplinary research at the university.

The School of Medicine received a $1.3 million grant from The Leona M. and Harry B. Helmsley Charitable Trust to support the work of Parakkal Deepak, MBBS, and Alfred H.J. Kim, MD, PhD. They will study antibody responses after vaccination against SARS-CoV-2 in patients with inflammatory bowel disease and other autoimmune diseases.